170 related articles for article (PubMed ID: 6633999)
1. Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen.
Eddy GL; Schlaerth JB; Nalick RH; Gaddis O; Nakamura RM; Morrow CP
Obstet Gynecol; 1983 Dec; 62(6):736-40. PubMed ID: 6633999
[TBL] [Abstract][Full Text] [Related]
2. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and postmolar trophoblastic disease.
Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
5. The role of contraception in the development of postmolar gestational trophoblastic tumor.
Deicas RE; Miller DS; Rademaker AW; Lurain JR
Obstet Gynecol; 1991 Aug; 78(2):221-6. PubMed ID: 1648697
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study).
Curry SL; Schlaerth JB; Kohorn EI; Boyce JB; Gore H; Twiggs LB; Blessing JA
Am J Obstet Gynecol; 1989 Apr; 160(4):805-9; discussion 809-11. PubMed ID: 2540654
[TBL] [Abstract][Full Text] [Related]
7. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
8. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
9. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
10. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
11. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
[TBL] [Abstract][Full Text] [Related]
12. Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
Goldberg GL; Cloete K; Bloch B; Wiswedel K; Altaras MM
Br J Obstet Gynaecol; 1987 Jan; 94(1):22-5. PubMed ID: 2434125
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of women with recurrent molar pregnancies.
Lorigan PC; Sharma S; Bright N; Coleman RE; Hancock BW
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):288-92. PubMed ID: 10985882
[TBL] [Abstract][Full Text] [Related]
14. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
[TBL] [Abstract][Full Text] [Related]
15. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
[TBL] [Abstract][Full Text] [Related]
16. Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy.
Ho Yuen B; Burch P
Am J Obstet Gynecol; 1983 Jan; 145(2):214-7. PubMed ID: 6849356
[TBL] [Abstract][Full Text] [Related]
17. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
18. [Gestational trophoblastic tumors and recent clinical information].
Shimizu T; Yaegashi N
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
[TBL] [Abstract][Full Text] [Related]
19. Poor compliance with postmolar surveillance and treatment protocols by indigent women.
Massad LS; Abu-Rustum NR; Lee SS; Renta V
Obstet Gynecol; 2000 Dec; 96(6):940-4. PubMed ID: 11084182
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal contraception after evacuation of hydatid mole (author's transl)].
Donát J; Chalupa M
Cesk Gynekol; 1981 May; 46(4):286-9. PubMed ID: 7249096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
